← Leaderboards
Laura Lee Dupuis
Hospital For Sick Chldrn (Toronto)
$757,821
Attributed
$2,273,463
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $475.7K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,273,463 · 1
By mechanism
R01$2,273,463 · 1
Top collaborators
- Allison Grimes5 shared
- Lillian Sung5 shared
Most similar at Hospital For Sick Chldrn (Toronto)
Same institution · by research overlap
- Lillian Sung$11,430,743
- Allison Grimes$757,821
- Brian W McCrindle$4,774,647
- Diane K Wherrett$4,837,492
Others in their field
Other Emerging Leaders on “Distress”
- Christopher Barnaby Nelson · University Of Melbourne$28,282,846
- Pebbles Fagan · Univ Of Arkansas For Med Scis$7,657,723
- Pearl McElfish · Univ Of Arkansas For Med Scis$7,408,818
- Abby R Rosenberg · Seattle Children'S Hospital$7,381,606
- Ana-Maria Vranceanu · Massachusetts General Hospital$6,833,170
- Kristen Leann Gullo · Us Worldmeds, Llc$6,476,657
Research focus
DistressDocumentationControl Groups18 Year OldCross-Sectional StudiesAreaAdolescentAcuteCancer PatientAdoptionAdherenceCancer TherapyCare DeliveryCaringCharacteristicsChildCancer DiagnosisClinical CareClinical Practice GuidelineClinic VisitsCluster Randomized TrialCollectionAdultEffectiveness Of Interventions
Grant awards (5)
Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial$434,020
R01 · FY2024 · CA
Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial$440,242
R01 · FY2023 · CA
Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial$455,057
R01 · FY2022 · CA
Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial$468,460
R01 · FY2021 · CA
Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial$475,684
R01 · FY2020 · CA